Stableford Capital II LLC increased its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 292.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,766 shares of the conglomerate’s stock after buying an additional 13,984 shares during the quarter. Danaher accounts for 1.4% of Stableford Capital II LLC’s portfolio, making the stock its 17th biggest holding. Stableford Capital II LLC’s holdings in Danaher were worth $4,158,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. BlackRock Inc. bought a new stake in shares of Danaher in the 2nd quarter worth approximately $10,492,520,000. Jupiter Topco LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher in the second quarter valued at $1,287,949,000. Bank of America Corp DE acquired a new position in shares of Danaher in the second quarter valued at $993,846,000. Finally, Legal & General Group Plc bought a new position in Danaher in the second quarter worth $801,056,000. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Royal Bank Of Canada raised their price objective on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday. Guggenheim lifted their target price on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. The Goldman Sachs Group upped their target price on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Finally, UBS Group assumed coverage on shares of Danaher in a research report on Wednesday, September 9th. They issued a “buy” rating and a $250.00 price target for the company. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $235.23.
Danaher Trading Down 0.5%
Shares of Danaher stock opened at $217.33 on Friday. The stock has a market capitalization of $152.78 billion, a P/E ratio of 38.60, a price-to-earnings-growth ratio of 2.72 and a beta of 0.76. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a 50-day simple moving average of $210.88 and a 200 day simple moving average of $194.44. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 earnings per share. Research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s payout ratio is presently 28.42%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
See Also
- Five stocks we like better than Danaher
- Applied Digital’s Hidden Moat Could Unlock Massive Upside
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
